The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

MDC Annual Neuromuscular ‘Seed Grant’ Competition Launch

MDC is very excited to announce that their Annual Neuromuscular ‘Seed Grant’ Competition has launched and are now accepting applications until Feb 2, 2021 for Translational Science Seed Grants and Clinical Health Management Grants.

 

During a time when health research funding is challenged due to the COVID-19 pandemic and as many like-minded organizations/agencies have had to cancel their research competitions, MDC are very grateful that they are able to continue the momentum achieved over the last several years and provide critical research funds to help accelerate the understanding of neuromuscular disorders, identify pathways for future therapies and optimize care to improve the quality of life for Canadians affected by neuromuscular disorders

 

For information on the scope and guidelines of this year’s competition, please visit:

https://muscle.ca/researchers/funding-guideline-deadlines/

 

Applications with cross-cutting applicability to multiple neuromuscular disorders under MDC’s umbrella as well as disorder-specific ones are welcomed. Special consideration will be given to relevant meritorious applications in the following disease-specific areas, through designated funds generously provided by donors: Myotonic Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Immune-mediated Myopathies, Charcot-Marie-Tooth Disease, Pediatric Neuromuscular Disorders.

 

The total budget per project is $60,000 for 2 years.

 

Key Dates:
Full Application Deadline: February 2 at 11:59 pm (EST)
Notice of Decision: April 2020
Funding Start Date: May 1, 2020

 

All applications are available online at proposalCENTRAL.

Please contact MDC at with any questions or concerns.

mdc-grant-now-open-1200x1200-teal

Read next...

training

Dr. Hanns Lochmüller Presenting at Can-GARD / CCMG The Leading Strand Webinar Series

The Leading Strand webinar series is designed for genetics health professionals, led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers, clinicians and innovators. The series will help attendees anticipate, access, and apply new approaches and technologies for patient care.

Image of publications and text reading "new paper!"

Research Highlight: Study on COVID‑19 in Children With Neuromuscular Disorders

The NMD4C would like to highlight a paper from the Neuromuscular Working Group of the Spanish Pediatric Neurology Society, who have recently published a study which aims to describe the clinical characteristics and outcome of COVID-19 in the pediatric NMD patient population.

BrainRectangularBanner

The BRAIN Conference | Two-day online conference

BRAIN and its Guarantors are excited to announce a new venture: The BRAIN Conference! This two-day conference will feature a selection of fantastic speakers, invited by our conference Chairs from around the globe.

email-3249062_1280

January 2021 newsletter

1) New NMD4C monthly webinar series 2) Update on upcoming conferences 3) Two research participation opportunities 4) New research from NMD4C participants 5) Member spotlight on steering committee member Dr. James Dowling.

canada-nmd4c

NMD4C Year in Review

The NMD4C is proud to be where we are today. It is no easy task to unite a diverse community of stakeholders under a clear and united vision; even more difficult is to do so with the unique challenges every single member of our community faced during 2020.

bernard_brais_cropped (00000002)

Dr. Bernard Brais Featured in The Economist Report on Navigating Rare Neurological Diseases

NMD4C Investigator Dr. Bernard Brais is featured as a Canadian expert in The Economist Business Intelligence Unit’s recent report Navigating Rare Neurological Diseases: Meeting the Challenge for Policy Makers, Patients and Healthcare Professionals.